Category Archives: transparency
July 17, 2018 | FAH Policy Blog Team
Category: Pharmaceuticals, Transparency
The Federation of American Hospitals (FAH) sent a letter Monday to HHS Secretary Alex Azar commenting on the agency’s recently released Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
June 25, 2018 | FAH Policy Blog Team
Today, the Federation of American Hospitals (FAH) submitted comments to the Centers for Medicare & Medicaid Services’ (CMS) FY 2019 Inpatient Prospective Payment System (IPPS) proposed rule. The FAH’s comments were highlighted by responses to CMS’s proposals on Medicare Disproportionate Share Hospital (DSH) payments, payments for new and costly CAR T-Cell therapy, CMS’s quality and payment reporting programs, interoperability, long-term care hospital policies, and price transparency.
April 25, 2018 | Chip Kahn
Category: Financing, Medicare, Transparency
The newly released IPPS Proposed Rule goes a long way to putting patients first.
March 23, 2018 | FAH Policy Blog Team
Today, FAH submitted a letter in response to a request from Senators Cassidy, Bennet, Grassley, Carper, Young, and McCaskill. The Senators recently launched a bipartisan effort to increase health care price and information transparency to empower patients, improve quality, and lower costs.